Patienterne bør overvåges under behandlingen for tegn på kardiovaskulære virkninger, der kan kræve yderligere kardiovaskulær undersøgelse.
Patients should be monitored during treatment for evidence of cardiovascular effects that may require further cardiovascular examination and investigation.